XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Class C Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2020 $ 2,844 $ 40 $ 566,451 $ (192,013) $ 5,376 $ 382,698
Balance (in shares) at Dec. 31, 2020 250,000 39,837,058        
Net loss       (15,442)   (15,442)
Other comprehensive loss, net of taxes         (5,203) (5,203)
Stock-based compensation expense     11,151     11,151
Paid-in-kind preferred stock dividend           (6,196)
Issuance of common stock for board of director compensation     11     11
Issuance of common stock for board of director compensation (in shares)   229        
Cost of Series C preferred stock conversion     (1,800)     (1,800)
Issuance of common stock in public offering, net of costs of $17.7 million   $ 4 269,821     269,825
Issuance of common stock in public offering, net of costs of $17.7 million (in shares)   4,356,059        
Conversion of Series C preferred shares to common stock $ (765) $ 1 764      
Conversion of Series C preferred shares to common stock (in shares) (50,000) 1,312,860        
Paid-in-kind preferred stock dividend, including beneficial conversion feature $ 6,196   (6,196)      
Proceeds from exercise of stock options and warrants   $ 1 5,985     5,986
Proceeds from exercise of stock options and warrants (in shares)   701,360        
Balance at Sep. 30, 2021 $ 8,275 $ 46 846,187 (207,455) 173 647,226
Balance (in shares) at Sep. 30, 2021 200,000 46,207,566        
Balance at Jun. 30, 2021 $ 6,275 $ 46 841,537 (200,929) 1,100 648,029
Balance (in shares) at Jun. 30, 2021 200,000 45,892,448        
Net loss       (6,526)   (6,526)
Other comprehensive loss, net of taxes         (927) (927)
Stock-based compensation expense     4,148     4,148
Paid-in-kind preferred stock dividend, including beneficial conversion feature $ 2,000   (2,000)      
Proceeds from exercise of stock options     2,502     2,502
Proceeds from exercise of stock options (in shares)   315,118        
Balance at Sep. 30, 2021 $ 8,275 $ 46 846,187 (207,455) 173 647,226
Balance (in shares) at Sep. 30, 2021 200,000 46,207,566        
Balance at Dec. 31, 2021 $ 10,275 $ 50 1,100,287 (467,541) (1,243) 641,828
Balance (in shares) at Dec. 31, 2021 200,000 49,616,154        
Net loss       (27,897)   (27,897)
Other comprehensive loss, net of taxes         (41,685) (41,685)
Stock-based compensation expense     14,749     14,749
Paid-in-kind preferred stock dividend $ 6,000   (6,000)     (6,000)
Issuance of common stock for Cell&Co acquisition     479     479
Issuance of common stock for Cell&Co acquisition (in shares)   15,152        
Repurchase of common stock   $ (1) (24,999) (8,349)   $ (33,349)
Repurchase of common stock (in shares)   (1,341,571)       1,341,571
Vesting of restricted stock units (in shares)   97,062        
Proceeds from exercise of stock options     1,596     $ 1,596
Proceeds from exercise of stock options (in shares)   171,634,000        
Balance at Sep. 30, 2022 $ 16,275 $ 49 1,086,112 (503,787) (42,928) 555,721
Balance (in shares) at Sep. 30, 2022 200,000 48,558,431        
Balance at Jun. 30, 2022 $ 14,275 $ 49 1,081,747 (498,471) (29,176) 568,424
Balance (in shares) at Jun. 30, 2022 200,000 48,482,502        
Net loss       (5,316)   (5,316)
Other comprehensive loss, net of taxes         (13,752) (13,752)
Stock-based compensation expense     5,366     5,366
Paid-in-kind preferred stock dividend $ 2,000   (2,000)      
Vesting of restricted stock units (in shares)   4,500        
Proceeds from exercise of stock options     (999)     (999)
Proceeds from exercise of stock options (in shares)   71,429        
Balance at Sep. 30, 2022 $ 16,275 $ 49 $ 1,086,112 $ (503,787) $ (42,928) $ 555,721
Balance (in shares) at Sep. 30, 2022 200,000 48,558,431